An interventional study of Drug use counselling in Ischemic Attack, Transient and Stroke, sponsored by Norwegian University of Science and Technology. Completed at 6 sites in Norway. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2017-03-30.
Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment
Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack (TIA), but studies show that adherence to the prescribed drugs is often poor. This randomised controlled trial aims to investigate whether a systematic follow up of drug treatment using medication reconciliation, medication reviews and patient counselling by clinical pharmacists, improves adherence and/or decreases cardiovascular events the first three months and the first year after TIA. Patient satisfaction will also be compared between the two groups.
293 studies on the registry are indexed under Ischemic Attack, Transient; 64 are open to participants now.
This study's enrollment of 265 is above the median of 206 across 164 interventional studies indexed under Ischemic Attack, Transient.
Browse Ischemic Attack, Transient studies →Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Pharmacist conducting drug reconciliation, medication reviews and drug use counselling during hospitalisation. Follow up telephone calls 1 week, 1 month, 2 months and three months after discharge from hospital
Behavioral: Drug use counselling
The patients in the control group receive no intervention just treatment and follow up according to national standards
adherence to drug treatment in secondary prevention after TIA
self reporting of adherence
Time frame: 3 months
adherence to drug treatment in secondary prevention after TIA
self reporting of adherence
Time frame: 1 year
Persistence
Persistence measured by control of filled prescriptions
Time frame: 3 months
Incidence of stroke and cardiovascular events and deaths
Measured by using data from national health registries
Time frame: 3 months
degree of disability or dependence in the daily activities
measured by modified Rankin Scale and indirectly by level of care
Time frame: 3 months
patient satisfaction
Measured by using data from the Norwegian Stroke Registry
Time frame: 3 months
Persistence
Persistence measured by control of filled prescriptions
Time frame: 1 year
Incidence of stroke and cardiovascular events and deaths
Measured by using data from national health registries
Time frame: 1 year
degree of disability or dependence in the daily activities
measured by modified Rankin Scale and indirectly by level of care
Time frame: 1 year
patient satisfaction
Measured by using data from the Norwegian Stroke Registry
Time frame: 1 year
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology